Fintel reports that on March 17, 2025, UBS upgraded their outlook for Calumet (NasdaqGS:CLMT) from Sell to Neutral.
Analyst Price Forecast Suggests 99.20% Upside
As of March 5, 2025, the average one-year price target for Calumet is $26.26/share. The forecasts range from a low of $15.15 to a high of $34.65. The average price target represents an increase of 99.20% from its latest reported closing price of $13.18 / share.
See our leaderboard of companies with the largest price target upside.
The projected annual revenue for Calumet is 4,596MM, an increase of 9.71%. The projected annual non-GAAP EPS is 6.09.
What is the Fund Sentiment?
There are 156 funds or institutions reporting positions in Calumet. This is an increase of 49 owner(s) or 45.79% in the last quarter. Average portfolio weight of all funds dedicated to CLMT is 0.61%, an increase of 2.67%. Total shares owned by institutions increased in the last three months by 19.22% to 37,726K shares. 
The put/call ratio of CLMT is 0.19, indicating a bullish outlook.
What are Other Shareholders Doing?
Wasserstein Debt Opportunities Management holds 5,690K shares. In its prior filing, the firm reported owning 6,942K shares , representing a decrease of 22.01%.
Adams Asset Advisors holds 5,251K shares. No change in the last quarter.
Knott David M Jr holds 3,651K shares. In its prior filing, the firm reported owning 4,325K shares , representing a decrease of 18.45%. The firm increased its portfolio allocation in CLMT by 5.77% over the last quarter.
VTSMX - Vanguard Total Stock Market Index Fund Investor Shares holds 2,551K shares. In its prior filing, the firm reported owning 2,743K shares , representing a decrease of 7.55%. The firm increased its portfolio allocation in CLMT by 13.23% over the last quarter.
Two Seas Capital holds 1,783K shares. In its prior filing, the firm reported owning 310K shares , representing an increase of 82.62%. The firm increased its portfolio allocation in CLMT by 279.14% over the last quarter.
Calumet Specialty Products Partners Background Information
(This description is provided by the company.)
Calumet Specialty Products Partners, L.P. is a master limited partnership and a leading independent producer of high-quality, specialty hydrocarbon products in North America. Calumet processes crude oil and other feedstocks into customized lubricating oils, solvents and waxes used in consumer, industrial and automotive products; produces fuel products including gasoline, diesel and jet fuel. Calumet is based in Indianapolis, Indiana, and operates nine manufacturing facilities located in northwest Louisiana, northern Montana, western Pennsylvania, Texas, and eastern Missouri.
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
